AEGiS-SAPA: Govt 'not winning battle' against TB South African Press AssociationImportant note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu
DonateNow


Govt 'not winning battle' against TB

South African Press Association - October 17, 2006


Without special efforts to test multi-drug resistant (MDR) patients for resistance to other drugs, government will be unaware of the presence of extreme drug-resistant tuberculosis (XDR-TB) among TB patients, the director general of health said on Tuesday.

Thami Mseleku was speaking at a TB workshop in Pretoria attended by World Health Organisation (WHO) officials and delegates from the Southern African Development Community.

He said government had made diagnosis and treatment accessible to all communities and provided these services free, but "despite all these efforts, government is not winning the battle".

Mario Raviglione of WHO highlighted the challenges of the Global Plan, an initiative of WHO, to stop TB. He said communities were unaware and uninvolved and that the connection between TB and HIV was not clearly known.

"To eradicate XDR-TB may take a number of years because it's not a pandemic, it comes and goes," Raviglione said.

Raviglione said the set goals of trying to curb TB included engaging all care providers, enabling and promoting research and addressing the relationship between TB and HIV.

Medical officer Ernesto Jaramillio, also part of WHO, said diagnostic capacity in XDR-TB was only present in few countries.

"Evidence indicates that a strong TB control programme can make a fundamental contribution to preventing and controlling MDR-TB and XDR-TB," Jaramillio said.

Official statistics show an increase in the number of TB cases detected in South Africa over the years, with a low cure rate of 50% and a high "defaulter rate" of 10%.

These rates have resulted in a high proportion of MDR-TB patients.

Mseleku said lack of investment into research for TB drugs and new diagnostic tests had contributed to the country's poor TB position.

"We urge pharmaceutical and diagnostic companies to correct this gap with respect to new TB drugs and new diagnostic tests."

He said government needed to revise strategies to ensure early detection of resistant strains, and to have a surveillance system in place to monitor the resistance patterns.

Minister of Health Manto Tshabalala-Msimang could not attend the workshop because she was ill.


061017
SA061008


Copyright © 2006 - South African Press Association. Reproduction of this article (other than one copy for personal reference) must be cleared through the South African Press Association, Cotswold House, Greenacres Office Park, Cnr. Victory & Rustenburg Roads, VICTORY PARK, PO BOX 7766, JOHANNESBURG, 2000; Fax No: +27 11 782-1587/8, Tel No: +27 11 782-1600.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, and donations from users like you.

Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .